Navigating Success: A Year in Review at Fluigent – Client Chronicles and Company Highlights
Step into the dynamic world of Fluigent as we reflect on a remarkable year of achievements, collaborations, success, and growth.
In our video review, “Client Chronicles: A Year in Client Engagement,” provides a comprehensive overview of Fluigent’s global presence and achievements in 2023. Fluigent participated in prestigious events worldwide, from San Diego to Osaka through Berlin, showcasing its impact at events like MPS & EUROoCS World Summit in Berlin, MicroTAS in Katowice, Poland, and Medica in Düsseldorf.
Our journey extended across the United States, from SelectBIO’s Lab-on-a-Chip & Microfluidics World Congress in Laguna Hills to Cell Bio in Boston, where the energy and enthusiasm of the microfluidics community were truly inspiring.
Delve into our Harmony Beyond Borders, featuring impactful events in Japan, South Korea, China, and India, alongside our dedicated distributors and our significant meeting with our valued distributors in Singapore. Explore the Ambassadorial Allure, where we welcomed eight influential ambassadors and formed a groundbreaking partnership with the Scientific Center of The IPGG Technology platform.
Additionally, it covers exclusive interview with Mr. Gaspard Pardon and insights from Julia Sophie Böke of Leibniz IPHT Jena, highlighting Fluigent’s impact in Microfluidic research. The journey continues with reflections on Fluigent’s accomplishments, including its success in the OEM market.
The video concludes with Company Highlights, showcasing our vibrant team culture, nomination as an ‘Made in Val-de-Marne‘ Ambassador, welcoming new team members, and celebrating special events throughout the year, expressing gratitude to our customers, partners, and the Fluigent team for a year of innovation and collaboration. Thank you for being part of the Fluigent story, and here’s to another year of innovation, collaboration, and shared success together.
France HAMBER, our Chief Executive Officer, said: I am happy to see that in 2023 microfluidics is increasingly becoming an essential tool for Lab Workflow Automation. This technology has the advantage of delivering reductions in both cost and time, as well as being a new alternative for drug discovery through in vitro methods as opposed to testing on animals. I am proud that Fluigent is taking the lead in this market by delivering a step change in performance for next generation Life Sciences.
Sabine MERCIER, our CFO Chief Financial Officer and HRD Humand Ressources Director, said: I am delighted to have welcomed our new colleagues in 2023, who have brought us their skills, ideas and energy.
And very proud of the achievements of our Fluigent Collective, driven by the satisfaction of our Researcher and Industrial customers and at the top of technical & scientific innovation.
Looking forward to next year to continue the adventure!